Results 261 to 270 of about 89,894 (321)

Safety and Efficacy of Single Femoral Vein Puncture Technique for Double Access in Patent Foramen Ovale Closure Under ICE Guidance—A Single Center Experience of the “Two‐In‐One Technique”

Catheterization and Cardiovascular Interventions, Volume 105, Issue 6, Page 1427-1433, May 1, 2025.
ABSTRACT Background In selected patient populations, percutaneous closure of patent foramen ovale has been shown to be beneficial in preventing cerebral ischaemic events. In most cases, this procedure requires echocardiographic guidance, which may be transesophageal, transthoracic or intracardiac.
Pierre Guilleminot, Mathieu Mourot, Luc Lorgis, Romain Didier, Benjamin Ferrand, Gabriel Laurent, Catherine Vergely, Charles Guenancia, Thibaut Pommier   +8 more
wiley   +1 more source

Endothelin non-A, non-B receptor-mediated contraction in swine pulmonary vein.

, 1993
Sri Agus Sudjarwo, Masatoshi Hori, Hideaki Karaki, Michihiro Takai, Yoshihiro Urade, Toshikazu Okada   +5 more
openalex   +1 more source

Real Time Hemodynamic Monitoring During M‐TEER Using Electrical Cardiometry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral regurgitation is a common valvular dysfunction causing patient morbidity and mortality. Mitral transcatheter edge‐to‐edge repair (M‐TEER) allows grasping of valvular leaflets and approximation via a small implant, thus reducing mitral regurgitation (MR).
Andreas Goldschmied, Manuel Sigle, Ioannis Toskas, Monika Zdanyte, Mareike Bladt, Meinrad Gawaz, Tobias Geisler   +6 more
wiley   +1 more source

Influence of Jet Direction on Pulmonary Vein Flow Patterns in Severe Mitral Regurgitation

, 1995
Jonathan B. Mark, Shihab Ahmed, Roman Kluger, Susan Robinson   +3 more
openalex   +1 more source

Hitherto Unreported Pattern of Complex Obstructive Partial Anomalous Pulmonary Venous Drainage with Dual Drainage of Accessory Pulmonary Veins. [PDF]

Indian J Radiol Imaging
Garg D, Sharma A, Naganur SH, Singhal M.
europepmc   +1 more source

Safety and Efficacy of a Plug‐Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High‐Risk Indicated Patients

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Femoral large‐bore vascular access is an important and constantly increasing technique in interventional treatment. Temporary circulatory support in complex and high‐risk indicated patients (CHIP) presents a challenge in terms of postinterventional access site closure.
Jörg W. Schröder, Norman Mangner, Felix J. Woitek, Kai U. Markus, Michael Lehrke, Felix Vogt, Marlo Verket, Alexandros Siskos, Moritz Biener, Benjamin Meder, Nicolas M. Van Mieghem   +10 more
wiley   +1 more source

A Rare Case of Nitroglycerin Resistant Coronary Arterial Vasospasm During Coronary Artery Bypass Surgery

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary artery vasospasm following coronary artery bypass grafting (CABG) is a rare but potentially life‐threatening complication that can lead to myocardial ischemia, arrhythmias, and cardiogenic shock. Nitroglycerin‐resistant vasospasm, particularly involving the left main coronary artery (LMCA), poses significant diagnostic and ...
Dina Soliman, Cristian Castillo‐Rodriguez, Diego Cruz, John Abdelmalek   +3 more
wiley   +1 more source

Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies

Clinical Pharmacology in Drug Development, EarlyView.
Abstract This study (NCT04537715) investigated itraconazole (strong cytochrome P450 [CYP] 3A inhibitor) and rifampin (strong CYP3A inducer) on tazemetostat pharmacokinetics. In Part 1, patients received tazemetostat 400 mg orally on Days 1, 15, and 36, and 400 mg twice daily on Days 3‐14 and Days 21‐35.
Yingxue Chen, Renli Teng, Attila Szanto, Apoorva Kapopara, Rajat Bannerji, Julien Ogier, Devalingam Mahalingam   +6 more
wiley   +1 more source

Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase

Clinical Pharmacology &Therapeutics, EarlyView.
Apixaban could be a potential treatment option for the prevention of venous thromboembolism (VTE) in children with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL). This analysis describes an updated two‐compartment population pharmacokinetic (PPK) model that characterizes the PK variability of apixaban in pediatric patients with ALL ...
Praneeth Jarugula, Toni Ajavon‐Hartmann, Obinna Obianom, Elizabeth Ludwig, Christina Crevar, David Marchisin, Zhaoqing Wang, Weidong Chen, Bing He, Lesley G. Mitchell, Vilmarie Rodriguez, Glen Lew, Vidya Perera, Bindu Murthy, Samira Merali   +14 more
wiley   +1 more source